Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma.

Sagini MN, Klika KD, Orry A, Zepp M, Mutiso J, Berger MR

Open source

DOI
10.3389/fphar.2020.549804
Published
2020
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2020.549804,
  title = {Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma.},
  author = {Sagini MN and Klika KD and Orry A and Zepp M and Mutiso J and Berger MR},
  year = {2020},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2020.549804},
  url = {https://doi.org/10.3389/fphar.2020.549804}
}

RIS

TY  - JOUR
TI  - Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma.
AU  - Sagini MN
AU  - Klika KD
AU  - Orry A
AU  - Zepp M
AU  - Mutiso J
AU  - Berger MR
PY  - 2020
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2020.549804
UR  - https://doi.org/10.3389/fphar.2020.549804
ER  - 

APA

MN, S., KD, K., A, O., M, Z., J, M., & MR, B. (2020). Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2020.549804

Source records